Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Vivos Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q4 2024
- Shares held
- 351.2K
- −115.6K (−24.8%) vs. Q4 2024
- Total value
- $1.00M
- −$1.00M (−50.0%) vs. Q4 2024
- New holders
- 6
- 8 more added
- Sold out
- 4
- 1 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $3 | 0.00% | +1 | New |
| Steward Partners Investment Advisory, LLC | 8 | $23 | 0.00% | 00.0% | Unchanged |
| Kozak & Associates, Inc. | 49 | $110 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 130 | $370 | 0.00% | +10+8.3% | Added |
| Ronald Blue Trust, Inc. | 160 | $456 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $570 | 0.00% | −393−66.3% | Reduced |
| Group One Trading, L.P. | 228 | $650 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 547 | $1.56K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,314 | $3.75K | 0.00% | +1,240+1,675.7% | Added |
| UBS Group AG | 1,879 | $5.36K | 0.00% | +1,490+383.0% | Added |
| Credit Agricole S A | 2,365 | $6.74K | 0.00% | 00.0% | Unchanged |
| Ewa, LLC | 10,464 | $29.8K | 0.01% | +10,464 | New |
| State Street Corp | 11,822 | $33.7K | 0.00% | +11,822 | New |
| Northern Trust Corp | 12,511 | $35.7K | 0.00% | +12,511 | New |
| Royal Bank of Canada | 18,004 | $51.0K | 0.00% | +18,000+450,000.0% | Added |
| Commonwealth Equity Services, LLC | 34,000 | $97.0K | 0.00% | +8,000+30.8% | Added |
| Envestnet Asset Management Inc | 38,873 | $110.8K | 0.00% | +38,873 | New |
| Vanguard Group Inc | 42,634 | $121.5K | 0.00% | +32,055+303.0% | Added |
| Cutter & CO Brokerage, Inc. | 49,100 | $139.9K | 0.03% | +11,000+28.9% | Added |
| Geode Capital Management, LLC | 57,349 | $163.4K | 0.00% | +12,522+27.9% | Added |
| National Asset Management, Inc. | 69,531 | $198.2K | 0.01% | +69,531 | New |
| Anson Funds Management LP | 0 | $0 | 0.00% | −242,583−100.0% | Sold out |
| Strategic Wealth Designers | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −161−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |